Home > Best practice guidance for commissioners and providers of pharmaceutical services for drug users.

National Treatment Agency for Substance Misuse, Royal Pharmaceutical Society of Great Britain, Pharmaceutical Services Negotiating Committee, PharMAG, Pharmacy Misuse Advisory Group. [National Treatment Agency (UK)] (2006) Best practice guidance for commissioners and providers of pharmaceutical services for drug users. London: National Treatment Agency for Substance Misuse. 48 p.

[img]
Preview
PDF (Best practice guidance for commissioners and providers of pharmaceutical services) - Published Version
526kB

Offers best practice guidance for UK commissioners and providers developing service specifications for pharmacists providing services to drug users. Includes detailed sample service specifications, role clarification, and sample contract and service level agreement schedules.

It describes detailed sample service specifications for commissioning pharmaceutical services. Includes pharmacy needle exchange and dispensing, supervised administration (consumption of prescribed medicines) and pharmaceutical shared care for drug users. Includes information and advice to help commissioners and providers ensure pharmaceutical services follow best practice. Clarifies current and future roles for pharmacists in the provision of services to substance users. Explains the new pharmacy contract and how community pharmacists are paid.


Item Type:Evidence resource
Publication Type:Guideline
Drug Type:Alcohol or other drugs in general
Intervention Type:AOD disorder drug therapy, AOD disorder harm reduction, AOD disorder
Source:National Treatment Agency (UK)
Date:2006
Pages:48 p.
Publisher:National Treatment Agency for Substance Misuse
Corporate Creators:National Treatment Agency for Substance Misuse, Royal Pharmaceutical Society of Great Britain, Pharmaceutical Services Negotiating Committee, PharMAG, Pharmacy Misuse Advisory Group
Place of Publication:London
EndNote:View
Accession Number:HRB (Electronic Only)
Subjects:MA-ML Social science, culture and community > Community action > Community development
T Demographic characteristics > Pharmacist
J Health care, prevention and rehabilitation > Substance use prevention > Substance use harm reduction
VA Geographic area > Europe > United Kingdom
MP-MR Policy, planning, economics, work and social services > Programme planning, implementation, and evaluation > Programme planning (strategy)
HJ Treatment method > Substance disorder treatment method > Substance disorder drug therapy
J Health care, prevention and rehabilitation > Health care programme or facility > Community-based treatment (primary care)
MP-MR Policy, planning, economics, work and social services > Organisational development > Workforce / staff skills and training

Repository Staff Only: item control page